Hypoxia and drug resistance

Cited by (564)

Items 201–300 of 564

1. Anterior gradient 2 is a binding stabilizer of hypoxia inducible factor‐1α that enhances CoCl2‐induced doxorubicin resistance in breast cancer cells
   Zheqi Li, Qi Zhu, Lingyun Hu, Hao Chen, Zhenghua Wu, Dawei Li · 2015 · Cancer Science
2. Noninvasive Contrast-Free 3D Evaluation of Tumor Angiogenesis with Ultrasensitive Ultrasound Microvessel Imaging
   Chengwu Huang, Matthew R. Lowerison, Fabrice Lucien, Ping Gong, Diping Wang, Pengfei Song, Shigao Chen · 2019 · Scientific Reports
3. Hypoxia‐inducible factor 1α in oral cancer
   Peter A. Brennan, Neil Mackenzie, Marisol Quintero · 2005 · Journal of Oral Pathology and Medicine
4. Tumor Hypoxia: Chicken, Egg, or a Piece of the Farm?
   C. Norman Coleman, James B. Mitchell, Kevin A. Camphausen · 2002 · Journal of Clinical Oncology
5. Imaging and Analytical Methods as Applied to the Evaluation of Vasculature and Hypoxia in Human Brain Tumors
   Sydney M. Evans, Kevin W. Jenkins, W. Timothy Jenkins, Thomas J. Dilling, Kevin D Judy, Amy E. Schrlau, Alexander Russell Judkins, Stephen M. Hahn, Cameron J. Koch · 2008 · Radiation Research
6. TS‐1 enhances the effect of radiotherapy by suppressing radiation‐induced hypoxia‐inducible factor‐1 activation and inducing endothelial cell apoptosis
   Lihua Zeng, Guangfei Ou, Satoshi Itasaka, Hiroshi Harada, Xuejun Xie, Keiko Shibuya, Shinae Kizaka‐Kondoh, Akiyo Morinibu, Kazumi Shinomiya, Masahiro Hiraoka · 2008 · Cancer Science
7. Hypoxia selects for high-metastatic Lewis lung carcinoma cells overexpressing Mcl-1 and exhibiting reduced apoptotic potential in solid tumors
   Nobuko Koshikawa, C Maejima, K Miyazaki, Akira Nakagawara, Keizo Takenaga · 2005 · Oncogene
8. FDG-PET in monitoring therapy of breast cancer
   H. J. Biersack, H. Bender, HOLGER PALMEDO · 2004 · European Journal of Nuclear Medicine and Molecular Imaging
9. Oxygen-Based Nanocarriers to Modulate Tumor Hypoxia for Ameliorated Anti-Tumor Therapy: Fabrications, Properties, and Future Directions
   Xianqiang Li, Yue Wu, Rui Zhang, Wei Bai, Tiantian Ye, Shujun Wang · 2021 · Frontiers in Molecular Biosciences
10. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy
    Chuanhui Song, Wenguang Xu, Zheng Wei, Changjin Ou, Jinhui Wu, Jinlong Tong, Yu Cai, Xiaochen Dong, Wei Han · 2019 · Journal of Materials Chemistry B
11. A Mathematical Study of the Influence of Hypoxia and Acidity on the Evolutionary Dynamics of Cancer
    Giada Fiandaca, Marcello Edoardo Delitala, Tommaso Lorenzi · 2021 · Bulletin of Mathematical Biology
12. Hypoxia in Head and Neck Squamous Cell Carcinoma
    Zeng-Hong Li, Wei Gao, Jimmy Yu Wai Chan, Wai-Kuen Ho, Thian‐Sze Wong · 2012 · ISRN Otolaryngology
13. In Vivo pO2 Imaging of Tumors
    Boris Epel, Howard J. Halpern · 2015 · Methods in enzymology on CD-ROM/Methods in enzymology
14. Multiple pathways are involved in the anoxia response of SKIP3 including HuR-regulated RNA stability, NF-κB and ATF4
    Tomasz Rzymski, A Paantjens, J Bod, Adrian Llewellyn Harris · 2008 · Oncogene
15. Apoptosis and chemo‐resistance in colorectal cancer
    S. G. Prabhudesai, Sushil Rekhraj, Gretta Roberts, Ara Wardkes Darzi, Paul Ziprin · 2007 · Journal of Surgical Oncology
16. Erythropoietin and Tumor Angiogenesis
    Doménico Ribatti · 2009 · Stem Cells and Development
17. Cellular and cell-free studies of catalytic DNA cleavage by ruthenium polypyridyl complexes containing redox-active intercalating ligands
    Cynthia Ann Griffith, Adam S. Dayoub, Thamara Jaranatne, Nagham Alatrash, Ali H. Mohamedi, Kenneth Abayan, Zachary S. Breitbach, Daniel Wayne Armstrong, Frederick M. MacDonnell · 2017 · Chemical Science
18. Glucose transporter type 1 expression are associated with poor prognosis in patients with salivary gland tumors
    Yusuke Mori, Keiichi Tsukinoki, Masanori Yasuda, Masaki Miyazawa, Akihiro Kaneko, Yoshihisa Watanabe · 2006 · Oral Oncology
19. ESM1/HIF‑1α pathway modulates chronic intermittent hypoxia‑induced non‑small‑cell lung cancer proliferation, stemness and epithelial‑mesenchymal transition
    Xin Gu, Jie Zhang, Yuheng Shi, Haiji Shen, Yao Li, Yanyan Chen, Li Liang · 2020 · Oncology Reports
20. New antimetastatic hypoxic cell radiosensitizers: design, synthesis, and biological activities of 2-nitroimidazole-acetamide, TX-1877, and its analogues
    Soko Kasai, Hideko Nagasawa, Mao Yamashita, Mie Masui, Hideki Kuwasaka, Tomoko Oshodani, Yoshihiro Uto, T Inomata, Shigenori Oka, Seiichi Inayama et al. · 2001 · Bioorganic & Medicinal Chemistry
21. Noscapine sensitizes chemoresistant ovarian cancer cells to cisplatin through inhibition of HIF-1α
    Wenjing Su, Lei Huang, Qilin Ao, Qinghua Zhang, Xun Tian, Yong Fang, Yunping Lu · 2011 · Cancer Letters
22. Increased HIF-1α Expression Correlates With Cell Proliferation and Vascular Markers CD31 and VEGF-A in Uveal Melanoma
    F. Mouriaux, François Sanschagrin, Caroline Diorio, Solange Landreville, François Comoz, Edwige Petit, Myriam Bernaudin, Alain P. Rousseau, Dan Bergeron, Mohib Morcos · 2014 · Investigative Ophthalmology & Visual Science
23. 99mTc-(CO)3 His-Annexin A5 Micro-SPECT Demonstrates Increased Cell Death by Irinotecan During the Vascular Normalization Window Caused by Bevacizumab
    Christel Vangestel, Christophe Van de Wiele, Nancy Van Damme, Steven G. Staelens, Patrick Pauwels, Chris P.M. Reutelingsperger, Marc Peeters · 2011 · Journal of Nuclear Medicine
24. Nitric oxide attenuates resistance to doxorubicin in three-dimensional aggregates of human breast carcinoma cells
    Caroline Muir, Michael A. Adams, Charles H. Graham · 2005 · Breast Cancer Research and Treatment
25. Boosting two-photon photodynamic therapy with mitochondria-targeting ruthenium–glucose conjugates
    Jiangping Liu, Xinxing Liao, Kai Xiong, Shi Kuang, Chengzhi Jin, Liang‐Nian Ji, Hui Chao · 2020 · Chemical Communications
26. Theoretical evaluation of adiabatic and vertical electron affinity of some radiosensitizers in solution using FEP, ab initio and DFT methods
    Teodorico C. Ramalho, Ricardo Bicca de Alencastro, Mauro Aquiles La-Scalea, José Daniel Figueroa‐Villar · 2004 · Biophysical Chemistry
27. Etoposide‐resistant HT‐29 human colon carcinoma cells during glucose deprivation are sensitive to piericidin A, a GRP78 down‐regulator
    Ji‐Hwan Hwang, Ju‐Young Kim, Mi‐Ran Cha, In‐Ja Ryoo, Soo‐Jin Choo, Sung‐Min Cho, Yoshinori Tsukumo, Akihiro Tomida, Kazuo Shin‐ya, Yong‐Il Hwang et al. · 2007 · Journal of Cellular Physiology
28. Probing NMR parameters, structure and dynamics of 5‐nitroimidazole derivatives. Density functional study of prototypical radiosensitizers
    Teodorico C. Ramalho, Michæl Bühl · 2004 · Magnetic Resonance in Chemistry
29. Advances in molecular imaging for breast cancer detection and characterization
    Jennifer M. Specht, David A. Mankoff · 2012 · Breast Cancer Research
30. Developing Hypoxia‐Sensitive System via Designing Tumor‐Targeted Fullerene‐Based Photosensitizer for Multimodal Therapy of Deep Tumor
    Lei Li, Jiaju Fu, Jiahao Ye, Lei Liu, Zihao Sun, Haoyu Wang, Shuang‐Jie Tan, Mingming Zhen, Chunru Wang, Chunli Bai · 2024 · Advanced Materials
31. Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: An immunohistochemistry-based pilot study
    Zhen Wang, Qin Shi, Zemin Wang, Yongping Gu, Yueping Shen, Mao-ming Sun, Min Deng, Hua Zhang, Fang Junchu, Shuying Zhang et al. · 2011 · Pathology - Research and Practice
32. Hypoxia-Responsive Cobalt Complexes in Tumor Spheroids: Laser Ablation Inductively Coupled Plasma Mass Spectrometry and Magnetic Resonance Imaging Studies
    Edward S. O’Neill, Amandeep Kaur, David Bishop, Dmitry Shishmarev, Philip W. Kuchel, Stuart M. Grieve, Gemma Alexandra Figtree, Anna K. Renfrew, Paul Bonnitcha, Elizabeth J. New · 2017 · Inorganic Chemistry
33. Red Blood Cell-Membrane-Coated Poly(Lactic-co-glycolic Acid) Nanoparticles for Enhanced Chemo- and Hypoxia-Activated Therapy
    Anil P. Bidkar, Pallab Sanpui, Siddhartha Sankar Ghosh · 2019 · ACS Applied Bio Materials
34. Smoking Compromises Cause-specific Survival in Patients with Operable Colorectal Cancer
    Alastair J. Munro, Angela H.M. Bentley, Caroline Ackland, P.J. Boyle · 2006 · Clinical Oncology
35. Blood Hemoglobin Level and Treatment Outcome of Early Breast Cancer
    Michael Henke, Florian Sindlinger, Hans Ikenberg, Thomas Alexander Gerds, Martin Christian Schumacher · 2004 · Strahlentherapie und Onkologie
36. Tissue‐Penetrating, Hypoxia‐Responsive Echogenic Polymersomes For Drug Delivery To Solid Tumors
    Prajakta Kulkarni, Manas K. Haldar, Fataneh Karandish, Matthew I. Confeld, Rayat Hossain, Pawel P P Borowicz, Kara N. Gange, Lang Xia, Kausik Sarkar, Sanku Mallik · 2018 · Chemistry - A European Journal
37. HIF‐1α is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5‐FU chemotherapy
    Jun Nakamura, Yoshihiko Kitajima, Keita Kai, Kazuyoshi Hashiguchi, Masatsugu Hiraki, Hirokazu Noshirο, Kohji Miyazaki · 2009 · International Journal of Cancer
38. Nitric oxide signalling and cellular adaptations to changes in oxygenation
    Lynne-Marie M Postovit, Richard Sullivan, Michael A. Adams, Charles H. Graham · 2004 · Toxicology
39. Single‐cell measurement of the uptake, intratumoral distribution and cell cycle effects of cisplatin using mass cytometry
    Qing Chang, Olga Ornatsky, Cameron J. Koch, Naz Chaudary, Delphine Tamara Marie-Egyptienne, Richard Peter Hill, Scott D. Tanner, David William Hedley · 2014 · International Journal of Cancer
40. The Role for Liposomal Drug Delivery in Molecular and Pharmacological Strategies to Overcome Multidrug Resistance
    Lawrence D. Mayer, Jennifer A. Shabbits · 2001 · Cancer and Metastasis Reviews
41. Fibrinolytic Enzyme Cotherapy Improves Tumor Perfusion and Therapeutic Efficacy of Anticancer Nanomedicine
    Kirtane, Ameya R., Sadhukha, Tanmoy, Kim, Hyunjoon, Khanna, Vidhi, Koniar, Brenda, Panyam, Jayanth · 2017 · Cancer Research
42. The action and resistance mechanisms of Lenvatinib in liver cancer
    Anna Buttell, Wei Qiu · 2023 · Molecular Carcinogenesis
43. Hemoglobin‐based oxygen carrier enhanced tumor oxygenation: A novel strategy for cancer therapy
    Sharon Irene Gundersen, Andre Francis Palmer · 2008 · Biotechnology Progress
44. Combined Antitumor Therapy with Metronomic Topotecan and Hypoxia-Activated Prodrug, Evofosfamide, in Neuroblastoma and Rhabdomyosarcoma Preclinical Models
    Libo Zhang, Paula M. Marrano, Bing Heng Wu, Sushil Kumar, Paul Scott Thorner, Sylvain Baruchel · 2015 · Clinical Cancer Research
45. Hypoxia differently modulates the release of mitochondrial and nuclear DNA
    Amaëlle Otandault, Jean-Daniel Abraham, Zahra Al Amir Dache, Abdelnaby Khalyfa, Isabelle Jariel‐Encontre, Thierry Forné, Corinne Prévostel, Salem Chouaı̈b, David Gozal, Alain Roger Thierry · 2020 · British Journal of Cancer
46. Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers
    Nathaniel M. Braman, Prateek Prasanna, Kaustav Bera, Mehdi Alilou, Mohammadhadi Khorrami, Patrick Leo, Maryam Etesami, Manasa Vulchi, Paulette Turk, Amit Banwari Gupta et al. · 2022 · Clinical Cancer Research
47. The retinoblastoma protein-associated cell cycle arrest in S-phase under moderate hypoxia is disrupted in cells expressing HPV18 E7 oncoprotein
    Øystein Åmellem, J. A. Sandvik, Trond Stokke, E O Pettersen · 1998 · British Journal of Cancer
48. Synthetic lethality between BRCA1 deficiency and poly(ADP-ribose) polymerase inhibition is modulated by processing of endogenous oxidative DNA damage
    Sara Giovannini, Marie-Christine Weller, Simone Repmann, Holger Moch, Josef Jiricny · 2019 · Nucleic Acids Research
49. Selective anticancer strategies via intervention of the death pathways relevant to cell transformation
    Q-X Li, Dihua Yu, G Liu, Ning Ke, J.F. McKelvy, Flossie Wong‐Staal · 2008 · Cell Death and Differentiation
50. Inhibition of Orthotopic Human Bladder Tumor Growth by Lentiviral Gene Transfer of Endostatin
    Eiji Kikuchi, Sílvia Menéndez, Makoto Ohori, Carlos Cordon‐Cardo, Noriyuki Kasahara, Bernard H. Bochner · 2004 · Clinical Cancer Research
51. Synthesis, crystal structure description, electrochemical, and DNA-binding studies of “paddlewheel” copper(II) carboxylate
    Muhammad Iqbal, Sajid Ali, Ziaur Rehman, Niaz Muhammad, Manzar Sohail, Vedapriya Pandarinathan · 2014 · Journal of Coordination Chemistry
52. The relative importance of NADPH: cytochrome c (P450) reductase for determining the sensitivity of human tumour cells to the indolequinone EO9 and related analogues lacking functionality at the C-2 and C-3 positions
    Mark P. Saunders, Mohammed Jaffar, Adam Vorn Patterson, John Nolan, Matthew A. Naylor, Roger M. Phillips, Adrian Llewellyn Harris, Ian James Stratford · 2000 · Biochemical Pharmacology
53. Hypoxia-driven splicing into noncoding isoforms regulates the DNA damage response
    Danish Memon, Keren Dawson, Christopher Smowton, Xing Wei, Caroline Dive, Crispin J. Miller · 2016 · npj Genomic Medicine
54. Nanomedicine‐Enabled Modulation of Tumor Hypoxic Microenvironment for Enhanced Cancer Therapy
    Jinping Wang, Beilu Zhang, Jingyu Sun, Yuhao Wang, Hongjun Wang · 2019 · Advanced Therapeutics
55. Breaking barriers: we need a multidisciplinary approach to tackle cancer drug resistance
    James Ingham, Jia-Ling Ruan, Matthew A. Coelho · 2025 · BJC Reports
56. Paeonol enhances the sensitivity of human ovarian cancer cells to radiotherapy-induced apoptosis due to downregulation of the phosphatidylinositol-3-kinase/Akt/phosphatase and tensin homolog pathway and inhibition of vascular endothelial growth factor
    Hai-Mei Zhou, Qin-Xiang Sun, Yan Fen Cheng · 2017 · Experimental and Therapeutic Medicine
57. Using lentiviral vectors for efficient pancreatic cancer gene therapy
    Emmanuel Ravet, Hubert Lulka, Fabian Gross, Louis Casteilla, Louis Buscail, Pierre Cordelier · 2009 · Cancer Gene Therapy
58. Molecular and cellular processes underlying the hallmarks of head and neck cancer
    Jonathan M. Bernstein, Clare R. Bernstein, Catharine West, Jarrod James Homer · 2012 · European Archives of Oto-Rhino-Laryngology
59. Molecular imaging of tumor metabolism and apoptosis
    Uwe Haberkorn, Annette Markert, Walter Mier, Vasileios Askoxylakis, Annette Altmann · 2011 · Oncogene
60. Precision Medicine with Imprecise Therapy: Computational Modeling for Chemotherapy in Breast Cancer
    Matthew T. McKenna, Jared A. Weis, Amy Brock, Vito Quaranta, Thomas E. Yankeelov · 2018 · Translational Oncology
61. Influence of hypoxia on TRAIL-induced apoptosis in tumor cells
    Martin Weinmann, Patrizia Marini, Verena Jendrossek, Angelika Betsch, Barbara Goecke, Wilfried Budach, Claus Belka · 2004 · International Journal of Radiation Oncology*Biology*Physics
62. Identification and Development of Cyclic Peptide Inhibitors of Hypoxia Inducible Factors 1 and 2 That Disrupt Hypoxia-Response Signaling in Cancer Cells
    Andrew T. Ball, Soran Mohammed, Cyrielle Doigneaux, Reece M. Gardner, James W. Easton, S. J. Turner, Jonathan W. Essex, Garry Pairaudeau, Ali Tavassoli · 2024 · Journal of the American Chemical Society
63. Activation of P-glycoprotein (Pgp)-mediated drug efflux by extracellular acidosis: in vivo imaging with 68Ga-labelled PET tracer
    Oliver Thews, Wolfgang Dillenburg, Marco Fellner, Hans‐Georg Buchholz, Nicole Bausbacher, Mathias Schreckenberger, Frank Rösch · 2010 · European Journal of Nuclear Medicine and Molecular Imaging
64. Versatile Nitro-Fluorophore as Highly Effective Sensor for Hypoxic Tumor Cells: Design, Imaging and Evaluation
    Min Dai, Weiping P. Zhu, Yufang F. Xu, Xuhong H. Qian, Yan Liu, Yi Xiao, Yin You · 2008 · Journal of Fluorescence
65. Cobalt Chloride-induced Apoptosis and Extracellular Signal-regulated Protein Kinase Activation in Human Cervical Cancer HeLa Cells
    Hyun Jeong Kim, Seung-Ju Yang, Yoon Suk Kim, Tae Ue Kim · 2003 · BMB Reports
66. Imaging of HIF-1-Active Tumor Hypoxia Using a Protein Effectively Delivered to and Specifically Stabilized in HIF-1-Active Tumor Cells
    Takashi Kudo, Masashi Ueda, Yuji Kuge, Takahiro Mukai, Shotaro Tanaka, Maki Masutani, Yasushi Kiyono, Shinae Kizaka‐Kondoh, Masahiro Hiraoka, Hideo Saji · 2009 · Journal of Nuclear Medicine
67. Cetuximab enhances the effect of oxaliplatin on hypoxic gastric cancer cell lines
    Xu · 2010 · Oncology Reports
68. Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma
    Jun Sato, Yoshimasa Kitagawa, Yutaka Yamazaki, Hironobu Hata, Takuya Asaka, Masaaki Miyakoshi, Shozo Okamoto, Tohru Shiga, Masanobu Shindoh, Yuji Kuge et al. · 2014 · European Journal of Nuclear Medicine and Molecular Imaging
69. From tumor hypoxia to cancer progression: the implications of hypoxia-inducible factor-1 expression in cancers
    Fariz Nurwidya, Fumiyuki Takahashi, Kunihiko Minakata, Akiko Murakami, Kazuhisa Takahashi · 2012 · Anatomy & Cell Biology
70. Artemisinin-Loaded Mesoporous Nanoplatform for pH-Responsive Radical Generation Synergistic Tumor Theranostics
    Lidong Liu, Yuxin Leon Liu, Liyi Ma, Fang Mao, Anqi Jiang, Dongdong Liu, Lu Wang, Qi Jia, Jing Zhou · 2018 · ACS Applied Materials & Interfaces
71. Using YC-1 to overcome the radioresistance of hypoxic cancer cells
    So Young Moon, Hyo Won Chang, Jong‐Lyel Roh, Gui Chull Kim, Seung‐Ho Choi, Sang-wook Lee, Kyung‐Ja Cho, Soon Yuhl Nam, Sang Yoon Kim · 2009 · Oral Oncology
72. Ru( ii ) photosensitizers competent for hypoxic cancers via green light activation
    Francisco J. Ballester, Enrique Ortega, Delia Karina Maya Bautista, María Dolores Santana, José Ruiz · 2020 · Chemical Communications
73. Evaluation of the “Steal” Phenomenon on the Efficacy of Hypoxia Activated Prodrug TH-302 in Pancreatic Cancer
    Kate M. Bailey, Heather H. Cornnell, Arig Ibrahim‐Hashim, Jonathan W. Wojtkowiak, Charles P. Hart, Xiaomeng Zhang, Rafael A. Leos, Gary V. Martinez, Amanda F. Baker, Robert J. Gillies · 2014 · PLoS ONE
74. Physiological Mechanisms of Treatment Resistance
    Peter W. Vaupel · 2009 · Medical radiology
75. Angiogenic inhibitors in gastric cancers and gastroesophageal junction carcinomas: A critical insight
    Giuseppe Aprile, Elena Ongaro, Marzia Del Re, Stefania Eufemia Lutrino, Marta Bonotto, Laura Ferrari, Karim Rihawi, Giovanni Gerardo Cardellino, Nicoletta Pella, Romano Danesi et al. · 2015 · Critical Reviews in Oncology/Hematology
76. Role of molecular markers in the management of head and neck cancers
    Mariana B A Ferreira, Jonas A. de Souza, Ezra E.W. Cohen · 2011 · Current Opinion in Oncology
77. A high-selectivity fluorescent probe for hypoxia imaging in cells and a tumor-bearing mouse model
    Yue Wang, Xiaoyue Han, Xia Zhang, Li Zhang, Lingxin Chen · 2020 · The Analyst
78. Necrosis in the Tumor Microenvironment and Its Role in Cancer Recurrence
    Adi Karsch-Bluman, Ofra Benny · 2020 · Advances in experimental medicine and biology
79. Positron emission tomography imaging sheds new light on hypoxia and antitumor therapies
    Hanyi Fang, Xingyi Wang, Xiaoli Lan, Dawei Jiang · 2023 · Interdisciplinary medicine
80. Transplanting Normal Vascular Proangiogenic Cells to Tumor-Bearing Mice Triggers Vascular Remodeling and Reduces Hypoxia in Tumors
    Junpei Sasajima, Yusuke Mizukami, Yoshiaki Sugiyama, Kazumasa Nakamura, Toru Kawamoto, Kazuya Koizumi, Rie Fujii, Wataru Motomura, Kazuya Sato, Yasuaki Suzuki et al. · 2010 · Cancer Research
81. Reactive Oxygen Species-independent Oxidation of Thioredoxin in Hypoxia
    Harish Muniyappa, Shiwei Song, Christopher K. Mathews, Kumuda C. Das · 2009 · Journal of Biological Chemistry
82. Mass Spectrometry Analyses of Multicellular Tumor Spheroids
    Mitchell Acland, Parul Mittal, Noor A. Lokman, Manuela Klingler‐Hoffmann, Martin Klaus Oehler, Peter Hoffmann · 2017 · PROTEOMICS - CLINICAL APPLICATIONS
83. Cancer Stratification by Molecular Imaging
    Justus Weber, Uwe Haberkorn, Walter Mier · 2015 · International Journal of Molecular Sciences
84. DNA Interactions of pH-Sensitive, Antitumor Bis(aminoalcohol)dichloroplatinum(II) Complexes,
    Stefanie Zorbas‐Seifried, Christian G. Hartinger, Kristof Meelich, Mathea Sophia Galanski, Bernhard K. Keppler, Haralabos Zorbas · 2006 · Biochemistry
85. The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma
    Jiang Li, Hui Liu, Linfang Li, Hongping Wu, Chunhong Wang, ZI YAN, Ying Wang, Changqing Su, Huajun Jin, FUPING ZHOU et al. · 2012 · Oncology Reports
86. ‘Thiacalix[4]aniline’ as a highly specific extractant for Au( iii ) and Pd( ii ) ions
    Hiroshi Katagiri, Nobuhiko Iki, Yoshiaki Matsunaga, Chizuko Kabuto, Sotaro Miyano · 2002 · Chemical Communications
87. Effect of Heat-Inactivated Clostridium sporogenes and Its Conditioned Media on 3-Dimensional Colorectal Cancer Cell Models
    Madhura Satish Bhave, Ammar Mansoor Hassanbhai, Padmaja Anand, Kathy Qian Luo, Swee Hin Teoh · 2015 · Scientific Reports
88. Emerging strategies for delivering antiangiogenic therapies to primary and metastatic brain tumors
    Vasileios Askoxylakis, Costas Arvanitis, Christina S.F. Wong, Gino B. Ferraro, Rakesh K. Jain · 2017 · Advanced Drug Delivery Reviews
89. Past, Present, and Future of Oxygen in Cancer Research
    Paul G Okunieff, Bruce M. Fenton, Yuhchyau Chen · 2005 · Advances in experimental medicine and biology
90. Cytotoxicity of Ruthenium(II) Arene Complexes Containing Functionalized Ferrocenyl β-Diketonate Ligands
    Matthew Allison, Pablo Caramés‐Méndez, Benjamin J. Hofmann, Christopher M. Pask, Roger M. Phillips, Rianne M. Lord, Patrick C. McGowan · 2023 · Organometallics
91. Tissue oxygenation in a murine SCC VII tumor after X-ray irradiation as determined by EPR spectroscopy
    Hirotada G. Fujii, Koh‐ichi Sakata, Yoshihiro Katsumata, Sato Rikiya, Makoto Kinouchi, Masanori Someya, Shin‐ichiro Masunaga, Masato Hareyama, Harold M. Swartz, Hiroshi Hirata · 2008 · Radiotherapy and Oncology
92. Molecular imaging as a tool for translating breast cancer science
    David A. Mankoff · 2008 · Breast Cancer Research
93. Molecular Chemotherapy for Breast Cancer
    Adam Vorn Patterson, Adrian Llewellyn Harris · 1999 · Drugs & Aging
94. A Noncovalent Fluorescence Turn‐on Strategy for Hypoxia Imaging
    Wen‐Chao Geng, Shaorui Jia, Zhe Zheng, Zhihao Li, Dan Ding, Dong‐Sheng Guo · 2019 · Angewandte Chemie
95. Strategies To Assess Hypoxic/HIF-1-Active Cancer Cells for the Development of Innovative Radiation Therapy
    Chan Joo Yeom, Lihua Zeng, Yuxi Zhu, Masahiro Hiraoka, Hiroshi Harada · 2011 · Cancers
96. Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: Results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenografts
    Rachel E. Airley, Roger M. Phillips, Anthony Evans, John A. Double, A. Burger, Heiner H. Feibig, Catharine West, Ian James Stratford · 2005 · International Journal of Oncology
97. Oxygen as a regulator of cellular phenotypes in pregnancy and cancer
    Gendie E. Lash, Lynne-Marie M Postovit, Nicola E Matthews, Eugene Chung, Matthew T. Canning, Hugh F. Pross, Michael A. Adams, Charles H. Graham · 2002 · Canadian Journal of Physiology and Pharmacology
98. ERO1α is a novel endogenous marker of hypoxia in human cancer cell lines
    Norio Takei, Akihiro Yoneda, Marina Kosaka, Kaori Sakai, Yasuaki Tamura · 2019 · BMC Cancer
99. Fundamentals of Molecular Imaging: Rationale and Applications With Relevance for Radiation Oncology
    Heiko M. Schöder, Seng Chuan Ong · 2008 · Seminars in Nuclear Medicine
100. Large-Scale Analysis of Genes that Alter Sensitivity to the Anticancer Drug Tirapazamine in Saccharomyces cerevisiae
     Karen Hellauer, Guillaume Lesage, Anne‐Marie Sdicu, Bernard Turcotte · 2005 · Molecular Pharmacology